Thus, it would be more reasonable to evaluate the reliability of DE genes identified in only one dataset for a cancer type using the change directions of those genes showing at least marginally significant changes (e.g., p<0.1) in another dataset.
← all excerpts
Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes.
1
0.1000
0.1000